Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,385 | 36,855 | 35,723 | 52,593 | 25,320 |
| Marketable Securities | 10,080 | 33,651 | 69,866 | N/A | 5,000 |
| Receivables | 6,847 | 4,889 | 2,859 | 3,190 | 1,098 |
| Inventories | 3,054 | 2,137 | 2,102 | 1,993 | 2,168 |
| Other current assets | 0 | 0 | 0 | 226 | 322 |
| TOTAL | $55,957 | $78,107 | $111,102 | $58,002 | $33,908 |
| Non-Current Assets | |||||
| PPE Net | 11,396 | 11,052 | 8,591 | 7,074 | 2,836 |
| Intangibles | 2,376 | 1,870 | 1,197 | 1,832 | 1,362 |
| Other Non-Current Assets | 938 | 941 | 864 | 1,108 | 80 |
| TOTAL | $14,710 | $13,863 | $10,652 | $10,014 | $4,278 |
| Total Assets | $70,667 | $91,970 | $121,754 | $68,016 | $38,186 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | -373 | N/A | 37 | 638 | 1,000 |
| Accounts payable and accrued liabilities | 4,376 | 5,111 | 3,863 | 2,445 | 1,201 |
| Accrued Expenses | 3,861 | 5,187 | 3,375 | 3,076 | 1,521 |
| Other current liabilities | 2,725 | 1,995 | 2,962 | 3,015 | 2,659 |
| TOTAL | $10,589 | $12,293 | $10,237 | $9,174 | $6,381 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,890 | N/A | N/A | 63 | 583 |
| Other Non-Current Liabilities | 334 | 208 | 748 | 604 | 588 |
| TOTAL | $11,481 | $1,653 | $2,349 | $2,392 | $1,171 |
| Total Liabilities | $22,070 | $13,946 | $12,586 | $11,566 | $7,552 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,757 | 41,882 | 41,906 | 32,758 | N/A |
| Common Shares | 4 | 4 | 4 | 3 | 2 |
| Retained earnings | -304,669 | -262,472 | -224,209 | -190,566 | -168,463 |
| Other shareholders' equity | 29 | -10 | 10 | -436 | -436 |
| TOTAL | $48,597 | $78,024 | $109,168 | $56,450 | $30,634 |
| Total Liabilities And Equity | $70,667 | $91,970 | $121,754 | $68,016 | $38,186 |